CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-01 | Haut Donald Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2018-10-01 | Lieber Jonathan I Chief Financial Officer | Returned to the company · Employee Stock Option (Right to Buy) | −110,000 | 0 | ||
| 2018-10-01 | Lieber Jonathan I Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2018-10-01 | Lieber Jonathan I Chief Financial Officer | Returned to the company · Employee Stock Option (Right to Buy) | −28,000 | 0 | ||
| 2018-10-01 | Lieber Jonathan I Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2018-10-01 | Lieber Jonathan I Chief Financial Officer | Returned to the company · Employee Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2018-10-01 | Lieber Jonathan I Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-10-01 | Lieber Jonathan I Chief Financial Officer | Returned to the company · Employee Stock Option (Right to Buy) | −130,000 | 0 | ||
| 2018-10-01 | Lieber Jonathan I Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2018-10-01 | Lieber Jonathan I Chief Financial Officer | Returned to the company · Employee Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2018-10-01 | Gridley Adam President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −197,435 | 0 | ||
| 2018-10-01 | Gridley Adam President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +197,435 | 197,435 | ||
| 2018-10-01 | Gridley Adam President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −38,220 | 0 | ||
| 2018-10-01 | Gridley Adam President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +38,220 | 38,220 | ||
| 2018-10-01 | Gridley Adam President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −104,000 | 0 | ||
| 2018-10-01 | Gridley Adam President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +104,000 | 104,000 | ||
| 2018-10-01 | Gridley Adam President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −175,000 | 0 | ||
| 2018-10-01 | Gridley Adam President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2018-10-01 | Gridley Adam President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −175,000 | 0 | ||
| 2018-10-01 | Gridley Adam President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +175,000 | 175,000 |
Page 19 of 27 · 525 trades